君圣泰HTD1801治疗非酒精性脂肪性肝炎（NASH）的临床IIb 期研究（CENTRICITY研究）完成首例患者给药
Jan 11, 2023 08:00 HKT |  |
|
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
Jan 05, 2023 18:00 HKT | |
|
逆勢融資1億+美元，這家創新藥Biotech有何獨特之處？
Jan 05, 2023 11:52 HKT | |
|
逆势融资1亿+美元，这家创新药Biotech有何独特之处？
Jan 05, 2023 11:51 HKT | |
|
君聖泰完成1.07 億美元C/C+輪融資，加速推進在研管線的全球開發、商業化和商務拓展
Jan 05, 2023 08:01 HKT | |
|
君圣泰完成1.07 亿美元C/C+轮融资，加速推进在研管线的全球开发、商业化和商务拓展
Jan 05, 2023 08:00 HKT | |
|
노보텍, 생명공학 쇼케이스 2023의 골드 스폰서
Dec 21, 2022 07:00 HKT |  |
|
Novotech 是 Biotech Showcase 2023 的金牌赞助商
Dec 20, 2022 15:00 HKT | |
|
Novotech 是 Biotech Showcase 2023 的金牌贊助商
Dec 20, 2022 15:00 HKT | |
|
Novotech is Gold Sponsor at Biotech Showcase 2023
Dec 20, 2022 11:00 HKT | |
|
数据显示 50% 的新试验位于亚太地区
Dec 16, 2022 07:00 HKT | |
|
數據顯示 50% 的新試驗位於亞太地區
Dec 16, 2022 07:00 HKT | |
|
자료 보고, 새로운 임상 시험 중 50%의 시험 장소가 아시아 태평양 지역에 위치
Dec 16, 2022 07:00 HKT | |
|
Data Shows 50% of New Trials Have Sites in Asia Pacific
Dec 15, 2022 10:00 HKT | |
|
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding
Dec 14, 2022 21:45 HKT |  |
|
Novotech 荣获 2022 年亚太地区 CRO 临床试验最佳实践奖
Dec 07, 2022 06:00 HKT | |
|
Novotech 榮獲 2022 年亞太地區 CRO 臨床試驗最佳實踐獎
Dec 07, 2022 06:00 HKT | |
|
노보텍, 임상 시험 모범 사례로 2022년 아시아 태평양 CRO 상 수상
Dec 07, 2022 06:00 HKT | |
|
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
Dec 06, 2022 11:00 HKT | |
|
AJG Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
Nov 17, 2022 08:00 HKT | |
|